RVW Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220K Hold
1,542
– – 0.01% 177
2026
Q2
$242K Hold
1,542
– – 0.02% 164
2026
Q1
$236K Sell
1,542
-606
-28% -$92.9K 0.02% 163
2025
Q4
$296K Hold
2,148
– – 0.02% 142
2025
Q3
$275K Hold
2,148
– – 0.02% 152
2025
Q2
$260K Sell
2,148
-100
-4% -$11.3K 0.02% 148
2025
Q1
$251K Buy
+2,248
New +$239K 0.02% 145

Other funds holding NVS

RVW Wealth's NVS Position: Q3 2026 in Review

RVW Wealth held its Novartis (NVS) position steady in Q3 2026 at 1,542 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #177.

RVW Wealth first reported a position in NVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $296K in Q4 2025. 674 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • RVW Wealth held 1,542 shares of Novartis worth $220K as of Q3 2026.
  • RVW Wealth left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.01% of RVW Wealth's portfolio in Q3 2026, its #177 holding.
  • RVW Wealth first reported a position in Novartis in Q1 2025 and has held it in 7 quarters since.
  • RVW Wealth's Novartis position peaked at $296K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on RVW Wealth's 13F filing for Q3 2026, filed 6 Oct 2026.